Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Bone Marrow Transplantation|January 16, 2008
Extramedullary relapses after allogeneic non-myeloablative stem cell transplantation in multiple myeloma patients do not negatively affect treatment outcomeM C Minnema, N W C J van de Donk, S Zweegman, et al.
Atherosclerosis|August 19, 2003
Plasma homocysteine and S-adenosylmethionine in erythrocytes as determinants of carotid intima-media thickness: different effects in diabetic and non-diabetic individuals. The Hoorn StudyA Becker, R M A Henry, P J Kostense, et al.
European Journal of Haematology|October 11, 2023
Treatment sequences and drug costs from diagnosis to death in multiple myelomaM R Seefat, D G J Cucchi, K Groen, et al.
Antimicrobial Resistance and Infection Control|February 18, 2022
Indwelling time of peripherally inserted central catheters and incidence of bloodstream infections in haematology patients: a cohort studyM G Caris, N A de Jonge, H J Punt, et al.
Leukemia|September 24, 2011
Impaired bortezomib binding to mutant β5 subunit of the proteasome is the underlying basis for bortezomib resistance in leukemia cellsN E Franke, D Niewerth, Y G Assaraf, et al.
Leukemia|February 5, 2011
Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statementM A Dimopoulos, A Palumbo, M Attal, et al.
Leukemia|February 6, 2014
Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myelomaM A Dimopoulos, X Leleu, A Palumbo, et al.
Thrombosis and Haemostasis|September 28, 2011
Gynaecological and obstetric bleeding in moderate and severe von Willebrand diseaseE M De Wee, H M Knol, E P Mauser-Bunschoten, et al.
Journal of Hematology & Oncology|January 18, 2018
Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert PanelJ Caers, B Paiva, E Zamagni, et al.
Annals of Hematology|April 8, 2011
Effect of thalidomide with melphalan and prednisone on health-related quality of life (HRQoL) in elderly patients with newly diagnosed multiple myeloma: a prospective analysis in a randomized trialSilvia G R Verelst, F Termorshuizen, C A Uyl-de Groot, et al.
Pageof 5